نتائج البحث

Impacts of CD36 Variants on Plasma Lipid Levels and the Risk of Early‐Onset Coronary Artery Disease: A Systematic Review and Meta‐Analysis.

• Authors : Luo, Zhi¹ (AUTHOR) ; Lv, Lingwei² (AUTHOR); Garcia, Victor (AUTHOR)

• Source: Cardiovascular Therapeutics. 2/25/2025, Vol. 2025, p1-13. 13p.

تفاصيل العنوان

Role of NF-κβ and Oxidative Pathways in Atherosclerosis: Cross-Talk Between Dyslipidemia and Candesartan.

• Authors : Hadi, Najah R.¹; Yousif, Nasser Ghaly²; Abdulzahra, Mohammed S.¹

• Source: Cardiovascular Therapeutics. Dec2013, Vol. 31 Issue 6, p381-387. 7p.

تفاصيل العنوان

Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.

• Authors : Zhang, Xiaodan¹ (AUTHOR); Xing, Lu^1,2 (AUTHOR); Jia, Xiaona^1,3 (AUTHOR)

• Source: Cardiovascular Therapeutics. 4/27/2020, p1-21. 21p.

تفاصيل العنوان

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.

• Authors : Krysiak, Robert¹; Gilowski, Wojciech^1,2; Okopien, Bogusław¹

• Source: Cardiovascular Therapeutics. Oct2015, Vol. 33 Issue 5, p270-274. 5p.

تفاصيل العنوان

New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.

• Authors : Foucher, Christelle¹; Aubonnet, Patrick²; Reichert, Petr³

• Source: Cardiovascular Therapeutics. Dec2015, Vol. 33 Issue 6, p329-337. 9p.

تفاصيل العنوان

Dyslipidemia in Chronic Kidney Disease: Are Statins Still Indicated in Reduction Cardiovascular Risk in Patients on Dialysis Treatment? R. Scarpioni et al. Dyslipidemia in Chronic Kidney Disease.

• Authors : Scarpioni, Roberto¹ ; Ricardi, Marco¹; Melfa, Luigi¹

• Source: Cardiovascular Therapeutics. Dec2010, Vol. 28 Issue 6, p361-368. 8p. 2 Charts.

تفاصيل العنوان

Effect of Switch to the Highest Dose of Rosuvastatin Versus Add-on-Statin Fenofibrate Versus Add-on-Statin Nicotinic Acid/Laropiprant on Oxidative Stress Markers in Patients with Mixed Dyslipidemia.

• Authors : Kei, Anastazia¹; Tellis, Constantinos²; Liberopoulos, Evangelos¹

• Source: Cardiovascular Therapeutics. Aug2014, Vol. 32 Issue 4, p139-146. 8p.

تفاصيل العنوان

Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidemia.

• Authors : Bełtowski, Jerzy¹

• Source: Cardiovascular Therapeutics. Winter2008, Vol. 26 Issue 4, p297-316. 20p. 3 Diagrams, 1 Graph.

تفاصيل العنوان

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia

• Authors : Robert Krysiak; Wojciech Gilowski; Bogusław Okopień

Subjects: Blood Glucose; Male; medicine.medical_specialty

• Source: Cardiovascular therapeutics. 33(5)

تفاصيل العنوان

Different Effects of Fenofibrate on Metabolic and Cardiovascular Risk Factors in Mixed Dyslipidemic Women With Normal Thyroid Function and Subclinical Hypothyroidism.

• Authors : Krysiak, Robert¹; Gilowski, Wojciech^1,2; Szkrobka, Witold¹

• Source: Cardiovascular Therapeutics. Dec2014, Vol. 32 Issue 6, p264-269. 6p.

تفاصيل العنوان